A research team has developed a new class of compounds that effectively inhibit both wild-type CDK9 and its drug-resistant ...

Researchers led by Université de Montréal pathology and cell-biology professor Marc Therrien have identified major structural ...

Everolimus, a novel proliferation inhibitor and immunosuppressive agent, may suppress cardiac-allograft vasculopathy. We conducted a randomized, double-blind, clinical trial comparing everolimus ...

Pirtobrutinib, a highly selective, noncovalent (reversible) BTK inhibitor, was designed to ... are neoplastic diseases resulting in a clonal proliferation of B cells. CLL is the most common ...

Although the benefit/risk of therapeutic inhibition of VSMC proliferation in atherosclerosis is unclear, experimental and human evidence strongly suggests the therapeutic potential of ...

Cell Cycle/Cell Proliferation Inhibitors for Cancer Therapy Session Date and Time: Monday, April 17, 2023, at 9:00 a.m. ET Bill Gates Kept Tabs On His Employees By Memorizing Their License Plates ...

Patients with vitiligo experience impacts on quality of life, emerging therapies offer promising prospects for more targeted ...

A study has uncovered a surprising link between diet, intestinal microbes and the efficacy of cancer therapy. A Ludwig Cancer Research study has uncovered a surprising link between diet, intestinal ...

In BRAF-driven melanoma cells treated with BRAF inhibitors, subpopulations of cells escape drug-induced quiescence through a nongenetic manner of adaptation and resume slow proliferation. Here, we ...

In some forms of cancer, these enzymes are present in high levels or overactive and inhibiting them can prevent the proliferation of cancer cells. Tyrosine kinase inhibitors therefore provide an ...